Dhanuka inks agreement with Bayer AG to acquire international rights to active ingredients Iprovalicarb and Triadimenol

With this acquisition, Dhanuka plans to expand its footprint in more than 20 countries, including the regions of LATAM, EMEA and Asia including India.

Dhanuka Agritech Limited, one of India’s leading agri input companies, has signed an agreement to acquire international rights to the active ingredients Iprovalicarb and Triadimenol. With this acquisition, Dhanuka plans to expand its footprint in more than 20 countries, including the regions of LATAM, EMEA and Asia including India. These products were invented by Bayer AG, a global leader in agriculture input solutions and farming innovations. This acquisition will enable Dhanuka to embark on a journey of global market expansion.

Under this acquisition, Dhanuka Agritech Limited will get all the rights for manufacturing and sale of Iprovalicarb and Triadimenol in more than 20 countries.  In this transaction, Dhanuka will acquire the global rights to the associated brand Melody (for Iprovalicarb) with sub-brands like Melody Duo, Melody Compact, Melodika and others. As part of the Agreement, the companies have agreed on a transition plan that allows Dhanuka to provide seamless service, ensuring no disruption for growers and customers globally. Further, Dhanuka will be shifting the manufacturing of at least one of the products to India, leveraging the capabilities of its manufacturing unit at Dahej, Gujarat. The agreement will strengthen Dhanuka’s market position by providing a jump to both the topline and bottom-line by selling its products in India and global markets.

Iprovalicarb is a fungicide from the Carboxylic Acid Amines (CAA) class, used for disease management caused by Oomycetes species in Horticulture crops.Triadimenol is a well-established product used in seed treatment for cereals and cotton as a solo formulation and as a part of multiple treatment seasonal program in coffee as a pre-mix. Triadimenol is a SBI class 1, DMI triazole fungicide to control various diseases.

“Dhanuka is excited to embark on this journey with Bayer AG, as we expand our footprint in these key markets. This agreement not only strengthens our market presence but also reinforces our commitment to delivering exceptional products and services to customers worldwide” said Harsh Dhanuka, Executive Director – Dhanuka Agritech Ltd.

This agreement highlights Dhanuka’s continued focus on strategic growth and commitment to maintaining strong relationships with customers and stakeholders. Dhanuka is confident that this will provide value to growers across the globe.

With this acquisition, Dhanuka plans to expand